This ongoing study uses minimal residual disease analysis at two follow-up points, to facilitate risk-adapted treatment stratification in ALL patients aged 1–18 years. In the current analysis ...

(A) Cytochrome P450 2D6 (CYP2D6) pharmacogenetics determined using the ratio of debrisoquine to its metabolite, 4-hydroxydebrisoquine, in 1,011 Swedish subjects. This population sample included a ...

This study aimed to identify and critique the current level of economic evidence available for thiopurine S-methyltransferase (TPMT) testing in clinical practice. Six economic evaluations of TPMT ...

This study aimed to identify and critique the current level of economic evidence available for thiopurine S-methyltransferase (TPMT) testing in clinical practice. Six economic evaluations of TPMT ...